Growth failure in Crohn's disease children: may the first treatment have a role?

Teresa Capriati, Carla Bizzarri, Anna Dilillo, Valerio Nobili, Salvatore Oliva, Antonella Diamanti

Research output: Contribution to journalArticlepeer-review


INTRODUCTION: Growth failure in children is a frequent feature of childhood-onset Crohn's disease (CD), and stunting can persist into adulthood. Growth is an important outcome by which to judge the effectiveness of therapies in children; currently available studies in CD children have focused on the short-term impact of treatments on growth, and there are limited data regarding the long-term effects of treatments upon growth. Areas covered: We designed the present article to review whether the first treatment performed in newly diagnosed CD children may have a role on the future growth course. We conducted a systematic literature search to identify relevant studies published on the PubMed database from January 2002 up to now. We found only six surveys that documented mid-term growth course in newly diagnosed CD patients. Expert commentary: In the last years there have been relevant advances in the clinical management of CD children; however, there is a lack of knowledge about the best strategy to reverse growth failure. Children treated with enteral nutrition have appropriate height and weight gain but do not reverse the growth course. Further surveys are required to better explore not only clinical outcomes but also long-term growth course following each therapeutic strategy.

Original languageEnglish
Pages (from-to)1-8
Number of pages8
JournalExpert Review of Clinical Immunology
Publication statusE-pub ahead of print - Nov 7 2018


Dive into the research topics of 'Growth failure in Crohn's disease children: may the first treatment have a role?'. Together they form a unique fingerprint.

Cite this